Ligand validation:6FMV

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6FMV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FMV_OLC_A_310	36%	56%	0.17	0.861	0.67	1	1	1	2	0	100%	1
6FMV_OLC_A_304	30%	54%	0.188	0.849	0.92	0.87	1	1	6	0	100%	1
6FMV_OLC_A_303	27%	56%	0.196	0.84	0.67	0.99	1	1	2	0	100%	0.87
6FMV_OLC_A_306	10%	51%	0.238	0.802	0.85	1.03	1	1	1	0	68%	0.68
6FMV_OLC_A_305	8%	58%	0.247	0.724	0.68	0.89	1	1	0	0	100%	1
6FMV_OLC_A_307	7%	52%	0.247	0.822	0.87	0.98	-	-	0	0	36%	0.36
6FMV_OLC_A_309	6%	53%	0.334	0.775	0.92	0.88	1	1	5	0	100%	1
6FMV_OLC_A_308	6%	57%	0.316	0.751	0.7	0.92	1	1	3	0	100%	1
6CB2_OLC_A_309	27%	53%	0.188	0.835	0.8	1	2	1	5	0	100%	1
5OON_OLC_A_305	14%	56%	0.249	0.823	0.79	0.87	1	1	0	0	88%	0.88
6FMW_OLC_A_305	14%	54%	0.259	0.827	0.75	1.01	1	1	0	0	88%	0.88
6FMT_OLC_A_303	5%	57%	0.327	0.746	0.72	0.93	1	1	1	0	92%	0.92
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.